Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children

NCT00192322 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

173

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: CAIV-T 10^7
BIOLOGICAL: CAIVT 10^5
BIOLOGICAL: Placebo
BIOLOGICAL: TIV

Sponsor

MedImmune LLC

Collaborators

[object Object]